Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form agreeing to take part in the study
- You currently live in Germany, Austria, or Switzerland
- You have been diagnosed with sickle cell disease, confirmed by a blood test or genetic test — this includes several types, such as HbSS, HbSC, HbS/beta-thalassemia, or other rarer forms of sickle cell disease (confirm with trial site if unsure which type you have)
Who may not be able to join:
- You carry only one copy of the sickle cell gene (known as "sickle cell trait") but do not have sickle cell disease itself — this alone does not qualify you for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joachim Kunz, Dr., Center for Child and Adolescent Medicine, University Medical Center Heidelberg
Phone: 06221 56 4555
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in incidence of sickle-cell disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.